Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-579-1 | CAS number: 987-65-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 29-30 March 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 2013
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Adenosine 5'-(tetrahydrogen triphosphate), disodium salt
- EC Number:
- 213-579-1
- EC Name:
- Adenosine 5'-(tetrahydrogen triphosphate), disodium salt
- Cas Number:
- 987-65-5
- Molecular formula:
- C10H14N5O13P3.2Na
- IUPAC Name:
- disodium hydrogen [({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]phosphonate
- Reference substance name:
- Water
- EC Number:
- 231-791-2
- EC Name:
- Water
- Cas Number:
- 7732-18-5
- Molecular formula:
- H2O
- IUPAC Name:
- Oxidane
- Reference substance name:
- Unknown impurities.
- Molecular formula:
- Not available as unknown impurities.
- IUPAC Name:
- Unknown impurities.
- Test material form:
- solid: crystalline
- Details on test material:
- Storage conditions: 2-8°C
Batch No: 11678500
Constituent 1
impurity 1
impurity 2
Test animals / tissue source
- Species:
- cattle
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: ABP, Perth, PH1 3XB
- Storage, temperature and transport conditions of ocular tissue (e.g. transport time, transport media and temperature, and other conditions): Cow eyes were collected from freshly slaughtered cattle, and placed into containers containing Hank’s balanced salt solution (HBSS). Transport to test facility was on the same day as slaughter. Cold packs were used to keep the contents cool.
- Time interval prior to initiating testing: Corneas were prepared and used for testing on the day of collection
- indication of any existing defects or lesions in ocular tissue samples: Upon receipt, eyes were rinsed with HBSS and examined for defects (scratches, opacity or neovascularisation) prior to use.Any eyes showing defects were rejected from further use.
- Indication of any antibiotics used: Not specified
Test system
- Vehicle:
- physiological saline
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied: 750 µL
- Concentration Test Item: 20.06%, w/v in physiological saline
NEGATIVE CONTROL: Physiological saline
- Amount(s) applied: 750 µL
- Concentration: Sodium Chloride 0.9%, w/v
- Batch no.: 16B29T2C
POSITIVE CONTROL : Imidazole
- Amount(s) applied (volume or weight with unit): 750 µl
- Concentration (if solution): 20.03%, w/v in physiological saline
- Batch no.: SLBP2962V - Duration of treatment / exposure:
- 4 h ± 10 min
- Number of animals or in vitro replicates:
- Three Corneas per test item and control
- Details on study design:
- SELECTION AND PREPARATION OF CORNEAS:
Upon receipt, eyes were rinsed with HBSS and examined for defects (scratches, opacity or neovascularisation) prior to use. Any eyes showing defects were rejected from further use. Corneas from undamaged eyes were dissected, leaving a sclera margin of ca 3 mm. Collected corneas were placed epithelial side down in HBSS at ambient temperature until use. Prior to mounting corneas the width of the cornea was measured using a ruler.
QUALITY CHECK OF THE ISOLATED CORNEAS
Corneas were then mounted, epithelial side forward, into pre-warmed corneal holders. Once mounted, both chambers of the cornea holders were filled with pre-warmed EMEM (Eagles Minimum Essential Medium) without phenol red. The posterior chamber was filled first to encourage the cornea to return to its original curvature, and care was taken to avoid the introduction of bubbles into the medium. Holders were then allowed to equilibrate for >1 h in an incubator.
Unless otherwise stated, all incubations of corneas were conducted in an incubator set to maintain 32°C (actual temperatures have been recorded in the raw data). At the end of the equilibration period, the medium in both chambers was replaced with fresh, EMEM without phenol red. Baseline opacity readings were then taken using an Opacitometer (Duratec Analysentechnik GmbH) comprising a Testo 545 luminometer with a photo diode and xenon halogen light source in a custom enclosure. Damaged corneas (opacity >7 opacity units) were rejected from further use.
TREATMENT METHOD: closed chamber. Prior to dosing, cornea holders were tipped forward to avoid contact between the dosing solution and the corneal epithelium. ATP, Di-Na (20.06%, w/v in physiological saline; 750 µL) was applied to the surface of three corneas using syringe. The negative control, physiological saline (750 µL) and the positive control, imidazole (20.03%, w/v in physiological saline; 750 µL), were also applied to the surface of three corneas each, using a syringe. The anterior chambers were then sealed with tape. To begin exposure, the corneal holders were tilted to a horizontal position, taking care to ensure that the entire epithelial surface was covered with the dosing solution. The dosed units were then returned to the incubator for 4 h ± 10 min.
REMOVAL OF TEST SUBSTANCE
EMEM with and without phenol red were pre-warmed prior to use. Following the exposure incubation, the test items and control solutions were removed from the anterior chambers through the holes using a vacuum pump. Corneas were then rinsed three times with EMEM with phenol red (ca 5 mL per rinse), removing the EMEM each time, then rinsed once with EMEM without phenol red (ca 5 mL), which was also removed. Finally, both chambers were refilled with EMEM without phenol red, and any bubbles introduced into the medium were removed.
POST-INCUBATION PERIOD: no
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: opacity readings were then taken using an Opacitometer (Duratec Analysentechnik GmbH) comprising a Testo 545 luminometer with a photo diode and xenon halogen light source in a custom enclosure. Gross damage or other changes were observed by visual assessment.
- Corneal permeability: Following the measurement of opacity, the EMEM in both chambers of the cornea holder wasremoved. Posterior chambers were refilled with EMEM without phenol red and sealed. Sodium fluorescein solution (5 mg/mL in EMEM without phenol red; ca 1 mL) was added to the anterior chambers. Cornea holders were rotated to the horizontal position, and incubated for 90 min ± 5 min in an incubator set to maintain a temperature of 32°C. At the end of the permeability test, EMEM from the posterior chambers was collected. These samples were stored overnight in a refrigerator set to maintain a temperature of 4°C.
Following overnight storage, triplicate aliquots from each sample (380 µL) were transferred into a 96 well plate, and analysed with a Multiskan Spectrum plate reader at 490 nm. Three blank wells containing EMEM without phenol red (380 µL) were analysed on the same plate, along with two aliquots of a quality control solution (sodium fluorescein, 10 µg/mL).
SCORING SYSTEM: In Vitro Irritancy Score (IVIS)
IVIS = Opacity change + (15 x A490 Value)
DECISION CRITERIA:
In accordance with OECD Test Guideline No. 437, irritancy was assigned on the basis of in vitro irritancy scores (IVIS), calculated from the opacity and permeability value for each cornea, as follows:
IVIS<=3: not classified according to GHS/CLP
3IVIS>55: Classified as Eye Damaging Category 1 according to GHS/CLP
Results and discussion
In vitro
Results
- Irritation parameter:
- in vitro irritation score
- Run / experiment:
- Single experiment
- Value:
- 18.5
- Vehicle controls validity:
- valid
- Remarks:
- IVIS: 0.0
- Positive controls validity:
- valid
- Remarks:
- IVIS: 106.60
- Remarks on result:
- not determinable
- Remarks:
- No Prediction can be made
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Test item treatement: Prior to baseline opacity checks cornea diameter was measured and the mean diameter for the 3 test item treated corneas was 2.23 cm.
The BCOP results were similar for all corneas and are presented in full in Table 1 (see Any other information on results incl. tables section).
- Visible damage on test system: not reported
ACCEPTANCE OF RESULTS:
- Negative and Positive Control Treatments: Prior to baseline opacity checks cornea diameter was measured. Negative and positive control corneas had a mean diameter of 2.33 cm and 2.23 cm, respectively. The negative control treatment gave opacity readings <5 and low permeability values. The classification achieved was “No Category”. The mean change in opacity after treatment was 1.53. The mean permeability (corrected for blank only) was 0.072. The positive control treatments gave mean IVIS scores of 106.60. The classification achieved was “Category 1”.
- Acceptance criteria met for negative control: yes, mean post treatment opacity of 1.53 (historical values range 3.83 +/- 1.82) / mean permeability corrected for blank of 0.072 (historical values range 0.045 +/- 0.043)
- Acceptance criteria met for positive control: yes, mean IVIS 106.60 (historical range: Mean +/- 2SD =66.29 to 169.36)
Any other information on results incl. tables
Table 1 BCOP Results for Controls and ATP, Di-Na (n=3)
Treatment |
Opacity Post Dose (Opacity Units, Uncorrected) |
Corrected* Opacity Change (Opacity Units) |
Permeability (A490), Corrected for Blank Only |
Permeability (A490), Corrected* |
IVIS |
IVIS (Mean) |
UN GHS Category** |
Physiological Saline (Negative Control) |
1.26 |
-1.96 |
0.020 |
-0.053 |
-2.75 |
0.00 |
No Category |
4.72 |
2.00 |
0.162 |
0.090 |
3.35 |
|||
3.98 |
-0.05 |
0.036 |
-0.037 |
-0.60 |
|||
Imidazole (PositiveControl) |
93.23 |
90.17 |
1.672 |
1.600 |
114.16 |
106.60 |
Category 1 |
87.47 |
84.61 |
1.499 |
1.427 |
106.01 |
|||
80.93 |
78.42 |
1.486 |
1.414 |
99.63 |
|||
ATP, Di-Na |
17.52 |
15.02 |
0.010 |
-0.063 |
14.08 |
18.50 |
No Prediction can be made |
22.18 |
19.04 |
0.008 |
-0.065 |
18.07 |
|||
27.67 |
24.31 |
0.007 |
-0.066 |
23.33 |
* Corrected for Negative Control
**Classifications from OECD Guidelines for the Testing of Chemicals No. 437 (2013)
Applicant's summary and conclusion
- Interpretation of results:
- other: no prediction could be made
- Conclusions:
- In conclusion, no prediction could be made for ATP, Di-Na (CAS 987-65-5) using the BCOP assay according to the UN GHS classifications and the CLP classification system.
- Executive summary:
The objective of this study was to evaluate the ocular irritation potential of ATP, Di-Na (CAS 987-65-5) using the Bovine Corneal Opacity and Permeability (BCOP) assay (OECD guideline 437).
Corneas were dissected from freshly obtained cow eyes, the cornea diameter was measured and they were mounted into corneal holders. Following a pre-dose equilibration period, and measurement of baseline opacity (using an opacitometer), the epithelial sides of the corneas were treated as follows:
ATP, Di-Na (20%, w/v; 750 µL), physiological saline or imidazole (20%, w/v) as negative and positive controls, respectively, were applied to three corneas each. Following exposure for 4 h ± 10 min, the test or control items were rinsed off.
The opacity of each cornea was then determined, followed by measurement of permeability by assessment of the passage of sodium fluorescein through the cornea. Irritancy was assigned on the basis of in vitro irritancy scores (IVIS). The results are summarised as follows:
The mean IVIS Score for ATP, Di-Na was 18.50
In conclusion, no prediction could be made for ATP, Di-Na (CAS 987-65-5) using the BCOP assay according to the UN GHS classifications and the CLP classification system.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.